Elan Board Issues Response to Indication of Interest from Royalty Pharma
Posted on February 25, 2013 at 09:19 AM EST
The Board of Elan Corporation, plc (NYSE: ELN ) (the Company) acknowledges this morning's announcement by Royalty Management, LLC (Royalty Pharma) regarding an indicative, conditional, proposal which may or may not lead to an offer being made for the entire issued share capital of the Company. As previously announced, in anticipation of executing
